DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 86 filers reported holding DESIGN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5 | -61.5% | 2,090 | +4.8% | 0.00% | – |
| Q2 2023 | $13 | -87.3% | 1,994 | -88.7% | 0.00% | – |
| Q1 2023 | $102 | -59.4% | 17,634 | -27.9% | 0.00% | – |
| Q4 2022 | $251 | -99.9% | 24,466 | +0.9% | 0.00% | -100.0% |
| Q3 2022 | $405,000 | +32.8% | 24,246 | +11.1% | 0.00% | – |
| Q2 2022 | $305,000 | -13.6% | 21,814 | -0.3% | 0.00% | – |
| Q1 2022 | $353,000 | +27.4% | 21,876 | +68.8% | 0.00% | – |
| Q4 2021 | $277,000 | +61.0% | 12,957 | +10.4% | 0.00% | – |
| Q3 2021 | $172,000 | -25.5% | 11,738 | +1.2% | 0.00% | – |
| Q2 2021 | $231,000 | – | 11,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 6,526,476 | $15,402,483 | 7.89% |
| Logos Global Management LP | 5,032,501 | $11,876,702 | 1.58% |
| Prosight Management, LP | 1,203,745 | $2,840,838 | 0.90% |
| TANG CAPITAL MANAGEMENT LLC | 1,350,000 | $3,186,000 | 0.45% |
| Soleus Capital Management, L.P. | 1,025,000 | $2,419,000 | 0.22% |
| RTW INVESTMENTS, LP | 2,512,986 | $5,930,647 | 0.12% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 180,000 | $425,000 | 0.09% |
| Corton Capital Inc. | 27,134 | $64,036 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 100,722 | $237,704 | 0.03% |
| Rock Springs Capital Management LP | 460,391 | $1,086,523 | 0.03% |